IE44791L - Substituted anilino-2-oxazolines and thiazolines - Google Patents

Substituted anilino-2-oxazolines and thiazolines

Info

Publication number
IE44791L
IE44791L IE770578A IE57877A IE44791L IE 44791 L IE44791 L IE 44791L IE 770578 A IE770578 A IE 770578A IE 57877 A IE57877 A IE 57877A IE 44791 L IE44791 L IE 44791L
Authority
IE
Ireland
Prior art keywords
thiazolines
oxazolines
substituted anilino
compounds
image
Prior art date
Application number
IE770578A
Other versions
IE44791B1 (en
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/668,385 external-priority patent/US4081547A/en
Priority claimed from US05/731,236 external-priority patent/US4103018A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of IE44791L publication Critical patent/IE44791L/en
Publication of IE44791B1 publication Critical patent/IE44791B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Substituted anilino-2-oxazolines and -thiazolines of the general formula <IMAGE> in which R, R1, R2, R3, Y, X1, X2 and Z have the meaning stated in Claim 1, are prepared by cyclisation of compounds of the general formula <IMAGE> in which Q is a reactive group. The compounds have antihypertensive effects. [GB1532351A]
IE578/77A 1976-03-19 1977-03-16 Substituted anilino-2-oxazolines and thiazolines IE44791B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/668,385 US4081547A (en) 1974-12-02 1976-03-19 Para-polyfluoroisopropyl-anilino-2-oxazoline compounds, pharmaceutical compositions and method of treating hypertension
US05/731,236 US4103018A (en) 1976-10-12 1976-10-12 2-[4-(Polyhalo-2-hydroxy-2-propyl)anilino]-2-oxazolin-4-ones and thiazolin-4-ones corresponding thereto

Publications (2)

Publication Number Publication Date
IE44791L true IE44791L (en) 1977-09-19
IE44791B1 IE44791B1 (en) 1982-04-07

Family

ID=27099887

Family Applications (1)

Application Number Title Priority Date Filing Date
IE578/77A IE44791B1 (en) 1976-03-19 1977-03-16 Substituted anilino-2-oxazolines and thiazolines

Country Status (9)

Country Link
JP (1) JPS52113960A (en)
AU (1) AU506147B2 (en)
CH (1) CH626356A5 (en)
DE (1) DE2711330A1 (en)
FR (1) FR2344548A1 (en)
GB (1) GB1532351A (en)
IE (1) IE44791B1 (en)
IL (1) IL51669A (en)
NL (1) NL7702846A (en)

Also Published As

Publication number Publication date
AU2335577A (en) 1978-09-21
FR2344548B1 (en) 1978-12-29
AU506147B2 (en) 1979-12-13
IL51669A (en) 1980-10-26
DE2711330A1 (en) 1977-09-22
CH626356A5 (en) 1981-11-13
GB1532351A (en) 1978-11-15
JPS52113960A (en) 1977-09-24
IL51669A0 (en) 1977-05-31
IE44791B1 (en) 1982-04-07
NL7702846A (en) 1977-09-21
FR2344548A1 (en) 1977-10-14

Similar Documents

Publication Publication Date Title
IE791967L (en) Cyclosporin derivatives
IE791895L (en) Alkanoyl prolines.
IE812713L (en) Herbicidal nicotinamide derivatives
IE811250L (en) Imidazole derivatives
IE45631L (en) 4-hydroxyphenylalkanolamine derivatives.
IE851734L (en) Isoindolinyl-alkyl-piperazines
IE800449L (en) Pyrazoline derivatives.
EP0192783A4 (en) 2-piperazinopyrimidine derivatives and process for their preparation.
IE791943L (en) Phenyl quinolizidines.
IE45109L (en) N-2-imidazolidinylidene-benzeneamine
IE822330L (en) 2,2-disubstituted-ethylamines
IE780198L (en) Oxadiazolopyrimidine derivatives
IE800253L (en) Pyridazinones.
IE44425L (en) N-(2,6-dihalophenyl)-thioureas, -isothioureas and¹-guanidines
IE42759L (en) Compounds containing a ureido or iso-ureido grouping
IE850185L (en) Benzopyrans
IE791552L (en) 1,2-disubstituted imidazolines
IE44791L (en) Substituted anilino-2-oxazolines and thiazolines
IE790920L (en) Benzofuran derivatives
IE792067L (en) Azatricyclic compounds
IE852246L (en) Penicillins
IE801686L (en) 1,3,4-thiadiazines
IE42672L (en) Thieno-tetrahydropyridine derivatives
IE792328L (en) Derivatives of dihydropyrrole and tetrahydropyridine.
IE44863L (en) 2-(amino or acylamino)-1-sulphonyl-benzimidazole¹derivatives.